INIS
patients
100%
levels
52%
indonesia
40%
hospitals
37%
risks
26%
diseases
26%
comparative evaluations
26%
children
25%
blood
24%
cancer
23%
covid-19
23%
control
22%
values
18%
correlations
16%
plasma
16%
laboratories
15%
viruses
15%
interventions
13%
therapy
12%
inflammation
12%
proteins
12%
antibodies
12%
evaluation
11%
iron
11%
thalassemia
11%
tumors
10%
sensitivity
10%
humans
10%
kidneys
10%
coronaries
10%
concentration
10%
biological markers
9%
pneumonia
9%
ovaries
9%
data
9%
adults
9%
specificity
9%
screening
9%
fibrin
9%
symptoms
9%
mortality
9%
ulcers
8%
detection
8%
clinical trials
8%
stem cells
8%
assessments
8%
communities
7%
liver
7%
women
7%
pediatrics
7%
ischemia
7%
hepatitis
7%
males
7%
surgery
7%
growth factors
6%
dna
6%
hiv
6%
antigens
6%
coronaviruses
6%
diarrhea
6%
vitamin d
6%
wounds
6%
diabetes mellitus
6%
accuracy
6%
glucose
6%
management
6%
hyaluronic acid
6%
tissues
6%
insulin
6%
antibiotics
6%
design
6%
receptors
6%
testing
6%
heart failure
6%
lymphocytes
5%
drugs
5%
urine
5%
interleukins
5%
genetics
5%
elevation
5%
hematology
5%
lipids
5%
performance
5%
fever
5%
genes
5%
java
5%
pancreas
5%
cholesterol
5%
molecules
5%
amino acids
5%
etiology
5%
Keyphrases
Indonesia
39%
Pada
23%
COVID-19
20%
Jakarta
16%
Indonesian
15%
Risk Factors
9%
β-Thalassemia (β-thal)
8%
Diabetic Foot Ulcer
8%
Acute Coronary Syndrome
7%
Hyaluronic Acid
7%
Platelet-rich Fibrin
7%
Interleukin-6
6%
Flow Cytometry
6%
Randomized Controlled Trial
6%
Depok
6%
Randomized Clinical Trial
6%
Thalassemia
5%
Vascular Endothelial Growth Factor
5%
Pandemi
5%
Hospital Preparedness
5%
Webinar
5%
Clopidogrel Resistance
5%
Laboratorium
5%
No Significant Difference
5%
Medicine and Dentistry
COVID-19
13%
Infection
13%
Diagnosis
11%
Diseases
8%
Severe Acute Respiratory Syndrome Coronavirus 2
7%
Diabetic Foot Ulcer
7%
Platelet-Rich Fibrin
7%
Restylane
6%
Cross Sectional Study
6%
Midazolam
5%
Neoplasm
5%
Drug Resistance
5%
Interleukin 6
5%
Randomized Controlled Trial
5%